Following the shock caused by a profit warning in February amid a price spike for whey, its key raw material, Glanbia sought to reassure shareholders this week with a partial restoration in its performance outlook for the rest of this year.  From adjusted earnings per share (EPS) of $0.14 in 2024, the nutrition group forecast earlier this year that profit would drop to between $0.124 and $0.13 this year. On Wednesday, Glanbia revised this guidance up to between $0.13 and $0.133 on the back of a more favourable outlook developing since the second quarter of this year. It also declared…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .